arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Scilex Holding Co

SCLX
$5.07 ▼ -0.26 (-4.88%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
26 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
73
Health
Good
Bullish
auto_awesome

Analytical Summary

Scilex Holding Co shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $34.9M
Dividend Yield
Revenue Growth -22.8%
Op. Margin -385.0%
ROIC 9.5%
FCF / Share $-0.98
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$7.64M
↓ -22.8%
Net Income Profit after all expenses
$-45.65M
↓ -75.0%
Operating Margin Operating profit as % of sales
-385.0%
↓ -3.1%
FCF / Share Free cash flow per share
$-0.98
↓ -508.5%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
66
Returns
100
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 26 quarters